News Focus
News Focus
Followers 590
Posts 27797
Boards Moderated 1
Alias Born 06/06/2013

Re: TRUMPFORPRES post# 7194

Saturday, 04/01/2017 8:11:36 PM

Saturday, April 01, 2017 8:11:36 PM

Post# of 20617
Trumpforpres with your opinion on South Korea, I have to strongly disagree. The deal is for a license and distribution agreement. This means J&H of South Korea will be buying $2mm worth of product from INNV annually for the next 10 years. This is not an arbitrary number, it's the contract price.

“We are pleased with the expedited process taken by our partner to secure approval to import and commercialize Zestra® in South Korea and we look forward to shipping our first product to that country this month,”

https://www.otcmarkets.com/stock/INNV/news/Innovus-Pharma-Announces-the-Approval-to-Commercialize-Zestra-reg--in-South-Korea-Through-its-Partner-J-amp-H-Co--LTD?id=150426&b=y

Secondly, I believe you are mistaken as to believing that this deal limits J&H to just South Korea. Here is a description of the company.

www.globalsources.com/si/AS/JH-trading/6008848245836/Homepage.htm

JH trading Co. Ltd,, a South Korea Agent,Distributor,Exporter exporting products to Eastern Europe,North America,Mid East/Africa.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today